Get started
Author

Jérôme Schwingel

Observed names: J. Schwingel, Jerome Schwingel
Observed institution: cts CaritasKlinikum Saarbrücken
ORCID: 0000-0002-2139-7014
Observed ORCID: 0000-0002-2139-7014
OpenAlex ID: A5015308189
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
2025 · Alessandro Audisio, Chiara Gallio, et al. · JAMA Oncology · 32
PDF
Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes
2020 · Roman Saternus, Jérôme Schwingel, et al. · Journal of Translational Autoimmunity · 30
PDF
Early Detection of Pancreatic Cancer
2023 · Jérôme Schwingel, Miriam Decker, et al. · Oncology Research and Treatment · 6
PDF
Acute pancreatitis following insertion of a gastric balloon—an unusual cause
2021 · Jérôme Schwingel, Sebastian Hüttinger, et al. · Deutsches Ärzteblatt international · 4
Percutaneous endoscopic colostomy to relieve malignant bowel obstruction
2024 · Jérôme Schwingel, Markus Casper, et al. · European Journal of Case Reports in Internal Medicine · 1
PDF
560P Practice heterogeneity in the management of dMMR/MSI status and NGS testing in gastroesophageal adenocarcinoma: Outcomes of an EORTC international survey
2026 · R. Pihlak, A. Cammarota, et al. · Annals of Oncology
Second-line therapy with Nal-IRI/5-FU/FA after failure of gemcitabine/nab-paclitaxel in advanced pancreatic cancer (PC): Predictive role of 1st-line therapy (PREDICT) and impact of quality of life (QoL).
2025 · Meinolf Karthaus, Jerome Schwingel, et al. · Journal of Clinical Oncology
PDF
Works count: 7
Citation count: 73
H-index: 4
I10-index: 2
Year
Topic
Type